Categories
Pharmaceutical

Increasing Risk Of Infection Is A Prime Driver Of Auto Disable Syringes Market Demand

A newly compiled research report by Fact.MR offers valuable perspectives on the Auto Disable Syringes market Sales & Demand and detailed insights pertaining to its growth prospects over the forecast period, 2018-2028.

This Research brings various growth forecasts, key trends, and notable segments ripe for upcoming investments.

Introduction

Auto disable syringes are single use syringe designed to block the barrel from depressing again or break the plunger after a single use. These are a type of safety syringes intended to avoid reuse of syringes

Advanced auto disable syringes have additional features such as needle stick prevention involving a sheath or hood which slides over the needle after single use. Another mechanism involves either manual or spring loaded retraction of the needle into the barrel of the syringe after single use.

To Remain ‘Ahead’ Of Your Competitors, Request for Brochure – https://www.factmr.com/connectus/sample?flag=B&rep_id=1053

Extensive rounds of primary and a comprehensive secondary research have been leveraged by the analysts to arrive at various estimations and projections for Sales & Demand of Auto Disable Syringes, its market share, production footprint, current launches, agreements, ongoing R&D projects, and market strategies.

These study approach a detailed segmental review.

Auto disable syringes Market: Segmentation

To gain an accurate assessment of the global auto disable syringes market, the report is segmented based on mechanism, clinical indications, end users, and region.

Based on mechanism, the global auto disable syringes market is divided into the following:

  • Retractable
    • Automatic Retractable
    • Manually Retractable
  • Non- Retractable
    • Slip
    • Lock
    • Needle covers
  • Others

Based on clinical indications, the global auto disable syringes market is segmented as below:

  • Vaccines
  • Infectious diseases
  • Inflammatory/Auto-Immune Diseases
  • Others

Based on end users, the global auto disable syringes market is segmented as below:

  • Hospitals and clinics
  • Ambulatory centers
  • Others

The Auto Disable Syringes Sales study analyzes crucial trends that are currently determining the growth of Auto Disable Syringes Market.

The Key trends Analysis of Auto Disable Syringes also provides dynamics that are responsible for influencing the future Sales and Demand of Auto Disable Syringes market.

Auto disable syringes Market: Snapshot

The global market for auto disable syringes is consolidated with a few large players dominating the scene. The global auto disable syringes market trends include a definite shift in favor of developing regions of Asia Pacific, such as India, and China.

There is also a strong trend of collaboration between large hospitals and service providers to benefit from infrastructure and skill training. Data sharing between players is another trend so as to reduce cost.

Some of the established vendors operating in the global auto disable syringes are NIPRO Medical Corporation, Becton, Dickinson and Company, JMI Syringes & Medical Devices Limited,

Boston Scientific Corporation, Baxter Healthcare Corporation, Medtronic plc. Smiths Medical, B. Braun Melsungen AG, Retractable Technologies, Inc., Terumo Medical Corporation, and others.

Enquiry Before Buying – https://www.factmr.com/connectus/sample?flag=EB&rep_id=1053

Company share analysis is used to derive the size of the global Auto Disable Syringes market. As well as a revenues of companies for the last several years provides the base for forecasting the market size and its Sales growth rate.

The Survey report highlights the growth factors and entry barriers for the key players and talks about the new trends emerging in the global Auto Disable Syringes market.

Such moves are expected to aid the shift of the market toward auto disable syringes. The use of bundling policy by the UNICEF where for every dose of injectable vaccine, a sufficient numbers of auto disable syringes, must be ensured is expected to trigger a large market shift in favor of auto disable syringes.

The restraints on the global auto disable syringes market are the presence of monopolistic actions of the major needle manufacturers and hospital purchasing departments. Lack of legislation concerning auto disable syringes especially in poor regions of Asia Pacific and Middle East and Africa may hamper the global auto disable syringes market.

The report covers following Auto Disable Syringes Market insights and assessment that are helpful for all participants involved in market:

  • Data on recently introduced regulations and their impact on key industries and on demand in Auto Disable Syringes
  • Latest industry Analysis on Auto Disable Syringes Market , with key analysis of market drivers, trends, and influencing factors
  • Key trends Analysis of Auto Disable Syringes market and changing consumer preferences in major industries.
  • Changing Auto Disable Syringes demand and consumption of diverse products
  • Major trends underlining funding by key investors in numerous countries
  • New investment opportunities in diverse technology and product or service types
  • Comprehensive data and Competitive analysis of Auto Disable Syringes major players
  • Auto Disable Syringes market sales in US will grow at a steady pace, driven by growing consumer confidence and economic recovery
  • Auto Disable Syringes demand forecast in Europe remains stable, as many countries such as UK, France, and Germany focus on boosting growth

NOTE: Our team are studying Covid-19 and its impact on the Sales growth of Auto Disable Syringes market and where necessary we will consider the Covid-19 footmark for better analysis of the market Demand and industries outlook.

Further, the Auto Disable Syringes market Survey report emphasizes the adoption pattern And Demand of Auto Disable Syringes Market across various industries.

The report mentions growth parameters in the regional markets.

Auto Disable Syringes Market: Regional Wise Outlook

The global auto disable syringes market is classified into regions viz. North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, and Middle East & Africa.

North America is expected to account for the largest share of the global auto disable syringes market owing to concentration of key market player, regulatory factors favoring the market, and large healthcare expenditure.

The Asia Pacific auto disable syringes market excluding Japan is expected to grow at the most significant CAGR owing to growth in healthcare expenditure.

China and India are expected to drive a lion’s share of the market growth owing to expanding healthcare and per capita income. Support by governments is expected to play a crucial role as exemplified by the Indian state of Andhra Pradesh which became the first to transit to auto disable syringes from July 28, 2018.

Europe led by Germany, France and the UK is expected to account for the second largest market for auto disable syringes. The Middle East & Africa global auto disable syringes market is expected to be skewed in favor of the gulf economies of Saudi Arabia, Kuwait, and Qatar.

A large part of global auto disable syringes market is captive, which necessitates close collaboration between players and organizations including governments, especially in the developing regions.

Request Customized Report as Per Your Requirements https://www.factmr.com/connectus/sample?flag=RC&rep_id=1053

Auto disable syringes Market: Drivers

Risk of infection and transmission of deadly ailments such as blood borne diseases, HIV, viral hepatitis and others is the prime driver of the global auto disable syringes market.

According to Centers for Disease Control and Prevention estimates approximately 1 in 10 new HIV diagnoses in the United States is attributed to drug use by injection.

HIV can survive in an infected needle for up to 42 days, depending on conditions such as temperature humidity and others. The Centers for Disease Control and Prevention attributes the direct cost of needle stick injuries between $539 and $672 million per year, which signifies the presence of a large unmet need for auto disable syringes.

The drawbacks of traditional glass syringes include chances of improper disinfection, and human errors. Disposable plastic body syringes can transfer diseases due to improper disposal. These drawbacks are driving a faster market adoption for auto disable syringes.

Regulatory drivers of the global auto disable syringes market include the support provided by governments and judiciary exemplified by the Needlestick Safety and Prevention Act, and the needle and syringe exchanges programs. Sixteen US states passed laws authorizing needle and syringe exchanges including California through nonprescription sale.

Rising awareness is exemplified by the portrayal of movies like Puncture which documents the attempts of inventor Thomas Shaw, to get his retractable needle accepted by health care facilities.

Support from bodies like the World Health Organization (WHO), UNICEF and the United Nations Population Fund (UNFPA) who fully endorsed and implemented the use of auto disable syringes in immunization services with an aim to phase out non-auto disable syringes is a strong driver of the market.

Competitive Landscape Analysis On Auto Disable Syringes Market:

In this report, leading market participants involved in the manufacturing of Auto Disable Syringes are covered. Analysis regarding their product portfolio, key financials such as market shares and sales, SWOT analysis and key strategies are included in this report.

Some of the key participants in the global Auto Disable Syringes Market include :

Some of the major players in the global auto disable syringes market are NIPRO Medical Corporation, Becton, Dickinson and Company, JMI Syringes & Medical Devices Limited, Boston Scientific Corporation, Baxter Healthcare Corporation, Medtronic plc., Smiths Medical, B. Braun Melsungen AG, Retractable Technologies, Inc., Terumo Medical Corporation, and others.

Collaboration between players and healthcare organizations is the most attractive strategy which can yield a premium and bulk sales. Thus, partnership with large hospitals and players is a neglected strategy which can yield dividends owing to faster adoption and lower cost.

After glancing through the report on global Auto Disable Syringes market Demand, readers will get valuable insight into the following: 

  • What opportunity Trends and drivers await the market in the forthcoming years?
  • Which of the regions are likely to offer plethora of opportunities for the global Auto Disable Syringes market Demand?
  • What are the emerging Sales revenue streams for the Auto Disable Syringes market?
  • What are the business models and technologies with disruptive potential?
  • Precise Year-on-Year growth of the Auto Disable Syringes market Share?

Analysts at Fact.MR give prominent data on recent technological developments and product developments in the Auto Disable Syringes Demand during the assessment period.

A comprehensive estimate on Demand of Auto Disable Syringes market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of Auto Disable Syringes market.

More Related Reports By Fact.MR On Healthcare Domain :

At-Home Celiac Testing MarketCeliac Testing market is set to gain growth in the forecast period 2021-2031 at a CAGR of 8.0%

Polysaccharide Hemostatic System MarketPolysaccharide Hemostatic System market is set to witness steady growth during 2021-2031

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office :
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E-Mail: sales@factmr.com

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates

Visit Our Website: https://www.factmr.com

 

Leave a Reply

Your email address will not be published. Required fields are marked *